Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens
Open accessThe DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Multicenter evaluation of 1,560 prospectively collected CSF specimens showing high agreement for multiple targets on the BioFire ME panel.
Overview
CoChat Summary
TL;DR
The FilmArray ME Panel rapidly detects 14 pathogens directly from CSF with high specificity and mostly high sensitivity in a multicenter evaluation of 1,560 prospectively collected specimens. Sensitivity/PPA was 100% for 9 of 14 analytes, with lower values for enterovirus (95.7%) and HHV-6 (85.7%), and no detections of *L. monocytogenes* or *N. meningitidis*.
Key findings
- Among 1,560 CSF specimens, FilmArray detected at least one pathogen in 136 (8.7%); the most prevalent targets were enterovirus (51/136, 37.5%), HHV-6 (22/136, 16.2%), *S. pneumoniae* (16/136, 11.8%), HSV-2 (12/136, 8.8%), and HPeV (12/136, 8.8%).
- Sensitivity/PPA was 100% for 9 of 14 analytes; enterovirus was 95.7% (44/46) and HHV-6 was 85.7% (18/21). *L. monocytogenes* and *N. meningitidis* were not detected by FilmArray or culture, so sensitivity could not be calculated.
- For *S. agalactiae*, there was one false-positive and one false-negative result, giving sensitivity 0% and specificity 99.9%. Specificity/NPA was ≥99.2% for all analytes, and overall agreement between FilmArray and comparator testing was 99.8% (21,791/21,840).
- The investigational-use-only EBV target had PPA 81.8% and NPA 98.5% and was excluded from the final commercial ME Panel.
Methods
- Multicenter prospective evaluation at 11 geographically distinct U.S. sites from February through September 2014; residual CSF specimens collected by lumbar puncture with ≥500 μl uncentrifuged CSF, enrolled within 7 days, and repeat specimens excluded. Of 1,643 acquired specimens, 83 were excluded, leaving 1,560 in the final analysis.
- FilmArray ME Panel testing used approximately 200 μl of CSF with automated nucleic acid extraction, reverse transcription, amplification, and analysis in approximately 1 h. Comparator methods were bacterial culture for bacterial analytes and PCR plus bidirectional sequencing for viral and yeast analytes; discrepant results were investigated, but reported performance used unresolved data only.
- Sensitivity/PPA was calculated as 100 × [TP/(TP + FN)] and specificity/NPA as 100 × [TN/(TN + FP)], with exact binomial two-sided 95% confidence intervals by the Wilson score method.
Limitations
- Stated: clinical data were analyzed retrospectively; full clinical data were not available for all patients; records for readmissions, follow-up treatment, or additional testing after LP were not accessible; standard CSF testing differed across sites and could affect discrepancy investigation; pretest probability for infectious ME was not controlled because enrollment was based on CSF culture submission with sufficient residual volume.
- Stated: there were 22 unresolved false-positive results, with possible contamination during aliquoting/testing or from oral flora/operator; the panel does not provide antibiotic susceptibility information and does not cover all bacterial CNS pathogens, so culture and Gram stain remain necessary.
- Evident from the text: low prevalence of many targets yielded few positive detections and wide or incalculable confidence intervals for several analytes, limiting precision of performance estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 24 Not checked · 141 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This leads to delays, which can have significant clinical consequences if therapy is delayed or incorrectly administered (9–11).”
What the sources say
- Partly supportedcites [9] Shah SS, Aronson PL, Mohamad Z, Lorch SA. 2011. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics 128:1153–1160. doi: 10.1542/peds.2011-0177. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Outcome Measures passage reports that death rates rose with each additional day before acyclovir treatment began in neonates with HSV infection. The paper does not establish that delays in CSF testing caused treatment delays, and it does not examine incorrectly administered therapy as an outcome. No page numbers are available in our copy. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [10] Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M. 1997. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA 278:491–496. [DOI] [PubMed] [Google Scholar] source
- Partly supportedcites [11] Cartwright K, Reilly S, White D, Stuart J. 1992. Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143–147. doi: 10.1136/bmj.305.6846.143. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Introduction links diagnostic or therapeutic delay in meningococcal disease to higher mortality, and the section on antibiotics before admission warns that delaying treatment to confirm a diagnosis can be fatal. The paper does not establish that delays in CSF testing cause treatment delays, or that incorrectly administered therapy has the stated clinical consequences. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It has been shown that cryptococcal antigen can remain positive for long periods of time after therapy, even when culture and smears are negative (40).”
What the sources say
- Supportedcites [40] Lu H, Zhou Y, Yin Y, Pan X, Weng X. 2005. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 43:2989–2990. doi: 10.1128/JCM.43.6.2989-2990.2005. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The paper reports that cryptococcal antigen remained detectable for months after successful therapy. Its results also state that antigen remained detectable when both fungal stain and culture had turned negative. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The definitive diagnosis of bacterial meningitis has been historically based on isolation in culture, which has a sensitivity of, on average, approximately 80% or greater (1).”
What the sources say
- Could not verifycites [1] Brouwer MC, Tunkel AR, van de Beek D. 2010. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23:467–492. doi: 10.1128/CMR.00070-09. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The table of contents lists a “CSF Cultures” section on p. 475, but its text is absent from our truncated copy. The Introduction reports that bacteria could not be cultured in 33% of cases in one Brazilian case series; that does not establish an average culture sensitivity or the historical basis of definitive diagnosis. Searches for CSF culture sensitivity and the approximately 80% figure did not find a passage that settles the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The FilmArray ME Panel demonstrated a sensitivity or positive percentage of agreement of 100% for 9 of 14 analytes.”
boostedn = 1,560- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All other assay targets were detected in 7 (5%) or fewer of the specimens.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims
Create a free account to see all 178 claims and to verify the 2 references still open.
- Probably not a substantial claim. 64
- It may state two separate claims as one. 78
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Overall accuracy between gold standard testing and the ME panel is reported between 93 and 99% (15–23).”
From Clinical Utilization of the FilmArray Meningitis/Encephalitis (ME) Multiplex Polymerase Chain Reaction (PCR) Assay (2019) · cites this paper as [17]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Causes of FP are related to sample contamination and cross-reactivity with other bacteria.8,10”
From Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis (2022) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Timely and accurate diagnosis of CNS infections is essential to avoid unnecessary antimicrobial therapy, reduce diagnostic uncertainty, limit hospital stay, and ultimately prevent morbidity and mortality.10,11”
From Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, CSF ME panel is not recommended to be performed in the CSF from shunt as it does not include Staphylococcus species, coagulase-negative staphylococci, Cutibacterium acnes, or Corynebacterium species, which are common causes of shunt infection [11].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have demonstrated the accuracy and clinical utility of FA-M/E in adults from North America and some European countries (5–8).”
From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
35 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The resulting performance characteristics were a PPA of 81.8% (95% CI, 61.5 to 92.7) with two false-negative results”
Reported 2 · recomputed 4
Citations
Cites
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583 · cited 13×
“They are critical pathogens in certain populations, including immunosuppressed patients (34), and are best detected in the CNS by molecular methods (23).”
BackgroundInfluentialTwo-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 1×
“While pleocytosis in the CSF is a sensitive marker of inflammation, several studies have shown cell counts may be normal in both adult and pediatric patients despite a diagnosis of bacterial meningitis (21, 22).”
BackgroundBacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930 · cited 3×
“Gram stain has been assessed in cases of suspected meningitis and reported to have sensitivity ranging from 10 to 93%, depending on the organism and population being tested (1), and a near 100% specificity (21).”
BackgroundEdmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631 · cited 1×
“Those surviving infection may have significant long-term sequelae, such as loss of limbs, problems with vision and hearing, seizures, and cognitive deficits (2).”
BackgroundBuss, S. N., Leber, A., Chapin, K., Fey, P. D., Bankowski, M. J., Jones, M. K., Rogatcheva, M., Kanack, K. J., & Bourzac, K. M. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02674-14 · Cited by 554 · cited 1×
“38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
ResultSelf-citation
Research works printed but not linked: 1
- BioFire Diagnostics. 2015. FilmArray Meningitis/Encephalitis (ME) Panel instruction booklet RF-Y-ASY-0118. BioFire Diagnostics, Salt Lake City, UT. [Google Scholar]
Cited by
Nervous system involvement after infection with COVID-19 and other coronaviruses
Wu, Y., Xu, X., Chen, Z., Duan, J., Hashimoto, K., Yang, L., Liu, C., & Yang, C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.03.031 · Cited by 2,046
Chiu, C. Y., & Miller, S. A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0113-7 · Cited by 1,620
Simner, P. J., Miller, S., & Carroll, K. C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix881 · Cited by 821
“Gram stain), 10(2-3) CFU/ml for growth in culture, and 10-100 CFU/mL for nucleic acid amplification based methods [31].”
MethodSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy381 · Cited by 641
“Although an FDA-cleared multiplex PCR targeting 14 organisms is available for diagnosing meningitis and encephalitis, it should not be considered a replacement for culture since clinical experience with the assay is limited and specificity issues have been reported [17, 18].”
BackgroundSelf-citationMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gilligan, P. H., Gonzalez, M. D., Jerris, R. C., Kehl, S. C., Patel, R., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy584 · Cited by 449
“Although an FDA-cleared multiplex PCR targeting 14 organisms is available for diagnosing meningitis and encephalitis, it should not be considered a replacement for culture since clinical experience with the assay is limited and specificity issues have been reported [17, 18].”
BackgroundSelf-citationEvaluation and Management of Well-Appearing Febrile Infants 8 to 60 Days Old
Pantell, R. H., Roberts, K. B., Adams, W. G., Dreyer, B. P., Kuppermann, N., O’Leary, S. T., Okechukwu, K., Woods, C. R., Byington, C. L., Lavelle, J. M., et al. (2021) · Pediatrics · doi:10.1542/peds.2021-052228 · Cited by 444
“Similarly, multiplex meningoencephalitis panels can provide results on CSF for 14 potential CSF pathogens in 1 hour.(43)”
BackgroundMiller, J. M., Binnicker, M. J., Campbell, S., Carroll, K. C., Chapin, K. C., Gonzalez, M. D., Harrington, A., Jerris, R. C., Kehl, S. C., Leal, S. M., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae104 · Cited by 376
Self-citationMessacar, K., Parker, S. K., Todd, J. K., & Dominguez, S. R. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02264-16 · Cited by 325
Syndromic Panel-Based Testing in Clinical Microbiology
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00024-17 · Cited by 308
“(75) conducted a large, prospective study of the MEP in which CSF samples (n 1,560) collected at 11 U.”
BackgroundTyler, K. L. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1708714 · Cited by 275
Tansarli, G. S., & Chapin, K. C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.11.016 · Cited by 263
Self-citationAdvanced Point‐of‐Care Testing Technologies for Human Acute Respiratory Virus Detection
Zhang, Z., Ma, P., Ahmed, R., Wang, J., Akin, D., Soto, F., Liu, B., Li, P., & Demirci, U. (2022) · Advanced Materials · doi:10.1002/adma.202103646 · Cited by 231
Application of Next Generation Sequencing in Laboratory Medicine
Zhong, Y., Xu, F., Wu, J., Schubert, J., & Li, M. M. (2021) · Annals of Laboratory Medicine · doi:10.3343/alm.2021.41.1.25 · Cited by 215
Lee, S. H., Ruan, S.-Y., Pan, S.-C., Lee, T.-F., Chien, J.-Y., & Hsueh, P.-R. (2019) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2019.10.009 · Cited by 206
“The principle and procedure of the assay have been described previously.(11) The panel included 15 bacteria (Acinetobacter calcoaceticus baumannii complex, Enterobacter cloacae complex, Escherichia coli, Haemophilus influenzae, Klebsiella aerogenes, Klebsiella oxytoca, Klebsiella pneumoniae group, Moraxella catarrhali…”
MethodThe diagnostic value of metagenomic next⁃generation sequencing in infectious diseases
Duan, H., Li, X., Mei, A., Li, P., Liu, Y., Li, X., Li, W., Wang, C., & Xie, S. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-020-05746-5 · Cited by 190
Acute encephalitis in immunocompetent adults
Venkatesan, A., Michael, B. D., Probasco, J. C., Geocadin, R. G., & Solomon, T. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32526-1 · Cited by 192
Liesman, R. M., Strasburg, A. P., Heitman, A. K., Theel, E. S., Patel, R., & Binnicker, M. J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01927-17 · Cited by 186
“able after the FilmArray and comparator molecular assays are negative (8, 17).”
BackgroundMetagenomics for neurological infections — expanding our imagination
Ramachandran, P. S., & Wilson, M. R. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0374-y · Cited by 176
From the Pipeline to the Bedside: Advances and Challenges in Clinical Metagenomics
Chiang, A. D., & Dekker, J. P. (2019) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiz151 · Cited by 176
The challenge of diagnostic metagenomics
Greninger, A. L. (2018) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2018.1487292 · Cited by 156
“bound on the number of targets that can be included [84,85].”
BackgroundBaddley, J. W., Forrest, G. N., & Practice, T. A. I. D. C. O. (2019) · Clinical Transplantation · doi:10.1111/ctr.13543 · Cited by 165
Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants
Olijve, L., Jennings, L., & Walls, T. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-17 · Cited by 160
“In a multicenter prospective study of CSF specimens of pediatric and adult patients, the FilmArray panel was shown to be sensitive and specific for HPeV and most other pathogens (107).”
BackgroundJha, N. K., Ojha, S. K., Jha, S. K., Dureja, H., Singh, S. K., Shukla, S. D., Chellappan, D. K., Gupta, G., Bhardwaj, S., Kumar, N., et al. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01767-6 · Cited by 162
Zhang, Y., Cui, P., Zhang, H., Wu, H., Ye, M.-Z., Zhu, Y., Ai, J., & Zhang, W. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02360-6 · Cited by 148
“Traditional cerebrospinal fluid (CSF) culture can identify approximately 30–40% CNS infections (including meningitis and encephalitis) [2], and some study even reported 80–90% detection rate in acute community-acquired bacterial meningitis patients [3].”
Hagen, F., Lumbsch, H. T., Arsic Arsenijevic, V., Badali, H., Bertout, S., Billmyre, R. B., Bragulat, M. R., Cabañes, F. J., Carbia, M., Chakrabarti, A., et al. (2017) · mSphere · doi:10.1128/msphere.00238-17 · Cited by 143
(2019) · doi:10.3390/ijms20205201 · Cited by 134
“Recently, PCR devices are available at Japanese hospitals, and rapid screening systems became available in 2018 [71].”
BackgroundWebber, D. M., Wallace, M. A., Burnham, C. D., & Anderson, N. W. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00343-20 · Cited by 142
“This feature has been useful in determining the etiology of meningitis following antibiotics (15); however, it may be a liability in the setting of respiratory infection, where PCR would be expected to overestimate bacterial count, increase the number of clinically irrelevant detections, and drive excessive antimicrob…”
BackgroundMethodTrujillo-Gómez, J., Tsokani, S., Arango-Ferreira, C., Atehortúa-Muñoz, S., Jimenez-Villegas, M. J., Serrano-Tabares, C., Veroniki, A.-A., & Florez, I. D. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101275 · Cited by 139
“Six studies were classified as low RoB in the reference test domain,10,17,18,22,26,29 and the remaining were judged as high RoB since it was not clear whether lumbar puncture and CSF sample Study Patient selection Index Test Bacteria reference test 1z Bact test Arora 2016 Low risk Low risk High risk High Bailu 2019 Lo…”
BackgroundInfluentialImmunomodulatory Strategies in Herpes Simplex Virus Encephalitis
Piret, J., & Boivin, G. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00105-19 · Cited by 146
“molecular reference diagnostic methods (24, 25).”
Recent and emerging technologies for the rapid diagnosis of infection and antimicrobial resistance
Trotter, A. J., Aydin, A., Strinden, M. J., & O’Grady, J. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.03.001 · Cited by 130
Methods for Rapid Diagnosis of Meningitis Etiology in Adults
Poplin, V., Boulware, D. R., & Bahr, N. C. (2020) · Biomarkers in Medicine · doi:10.2217/bmm-2019-0333 · Cited by 119
Radmard, S., Reid, S., Ciryam, P., Boubour, A., Ho, N., Zucker, J., Sayre, D., Greendyke, W. G., Miko, B. A., Pereira, M. R., et al. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00281 · Cited by 127
Messacar, K., Spence-Davizon, E., Osborne, C., Press, C., Schreiner, T. L., Martin, J., Messer, R., Maloney, J., Burakoff, A., Barnes, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30632-2 · Cited by 112
Messacar, K., Fischer, M., Dominguez, S. R., Tyler, K. L., & Abzug, M. J. (2017) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2017.10.007 · Cited by 136
Biomarkers of Infection and Sepsis
Opal, S. M., & Wittebole, X. (2019) · Critical Care Clinics · doi:10.1016/j.ccc.2019.08.002 · Cited by 111
Liu, B., Mulkey, S. B., Campos, J. M., & DeBiasi, R. L. (2023) · Pediatric Research · doi:10.1038/s41390-023-02930-6 · Cited by 114
Simner, P. J., Miller, H. B., Breitwieser, F. P., Pinilla-Monsalve, G. D., Pardo, C. A., Salzberg, S. L., Sears, C. L., Thomas, D. L., Eberhart, C. G., & Carroll, K. C. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00472-18 · Cited by 128
“by this panel but were positive by antigen testing, which was attributed to antigen persistence after receipt of therapy rather than the presence of a live organism (26).”
BackgroundSelf-citationGastli, N., Loubinoux, J., Daragon, M., Lavigne, J.-P., Saint-Sardos, P., Pailhories, H., Lemarié, C., Benmansour, H., d’Humières, C., Broutin, L., et al. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.11.014 · Cited by 113
Central Nervous System Infections
Giovane, R. A., & Lavender, P. D. (2018) · Primary Care: Clinics in Office Practice · doi:10.1016/j.pop.2018.05.007 · Cited by 102
Technological advances and changing indications for lumbar puncture in neurological disorders
Costerus, J. M., Brouwer, M. C., & van de Beek, D. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30033-4 · Cited by 114
Group B Streptococcal Neonatal Meningitis
Tavares, T., Pinho, L., & Andrade, E. B. (2022) · Clinical Microbiology Reviews · doi:10.1128/cmr.00079-21 · Cited by 111
“than 2 months, GBS was found only in the CSF of a patient older than 65 years, and most pediatric infectious agents were viruses (132, 135, 138).”
BackgroundHanson, K. E., & Couturier, M. R. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw494 · Cited by 99
“There have been 3 published reports evaluating the test performance of the ME panel [34] [35] [36] .”
BackgroundResultInfluentialPanels and syndromic testing in clinical microbiology
Dien Bard, J., & McElvania, E. (2020) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2020.08.001 · Cited by 92
“Primary among them is the risk of false-positive and false-negative results with the HSV-1 target.(21,22) Yet the performance was noted to be comparable with or superior to alternate HSV polymerase chain reaction (PCR) tests in other studies.”
ResultStrategies used by bacterial pathogens to cross the blood–brain barrier
Le Guennec, L., Coureuil, M., Nassif, X., & Bourdoulous, S. (2020) · Cellular Microbiology · doi:10.1111/cmi.13132 · Cited by 85
“Complications frequently occur, leading to high proportion of patients with unfavourable outcome and to neurological sequelae in survivors (Leber et al., 2016).”
BackgroundDavis, L. E. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000660 · Cited by 125
Graf, E. H., Farquharson, M. V., & Cárdenas, A. M. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.09.022 · Cited by 71
Soucek, D. K., Dumkow, L. E., VanLangen, K. M., & Jameson, A. P. (2019) · Journal of Pharmacy Practice · doi:10.1177/0897190017737697 · Cited by 72
“A time of 2 hours was chosen based on previous studies by Leber et al and Hansen et al which demonstrated that the average run time for each sample was 1 hour, with only 5 minutes of hands-on time required for setup.(5,6) We estimated that approximately another hour would be needed for CSF sample transport and communi…”
MethodPoint-Counterpoint: Meningitis/Encephalitis Syndromic Testing in the Clinical Laboratory
Dien Bard, J., & Alby, K. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.00018-18 · Cited by 70
“This is most evident in cases of viral infections where standard-of-care testing as part of the initial infectious disease workup may be limited to only HSV and enterovirus PCR, missing the more esoteric viral targets (HHV-6, CMV, and HPeV) that may not be high on the list for the differential diagnosis (2, 3).”
BackgroundSelf-citationManagement of Acute Bacterial Meningitis in Children
Alamarat, Z. I., & Hasbun, R. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s240162 · Cited by 100
Rapid diagnostic tests for infectious diseases in the emergency department
Bouzid, D., Zanella, M.-C., Kernéis, S., Visseaux, B., May, L. S., Schrenzel, J., & Cattoir, V. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.024 · Cited by 85
“Finally Listeria 187 monocytogenes was not tested during the clinical validation study, necessitating specific PCR 188 or cultures if there a high index of suspicion [30].”
Naccache, S. N., Lustestica, M., Fahit, M., Mestas, J., & Dien Bard, J. (2018) · Journal of Clinical Microbiology · doi:10.1128/jcm.01940-17 · Cited by 59
“original presubmission study, two false-positive HSV-1 results were reported (2).”
BackgroundResultInfluentialSelf-citationVetter, P., Schibler, M., Herrmann, J. L., & Boutolleau, D. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.12.013 · Cited by 64
Infectious Disease Complications in Patients with Cancer
Seo, S. K., Liu, C., & Dadwal, S. (2020) · Critical Care Clinics · doi:10.1016/j.ccc.2020.09.001 · Cited by 68
Gomez, C. A., Pinsky, B. A., Liu, A., & Banaei, N. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw245 · Cited by 53
“The diagnostic performance of the FilmArray ME panel was reported by Leber et al [3] in a well-designed prospective study, evaluating 1560 remnant CSF samples obtained as part of routine medical care, across 11 different sites in the United States.”
MethodPandey, U., Greninger, A. L., Levin, G. R., Jerome, K. R., Anand, V. C., & Dien Bard, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00313-20 · Cited by 61
“Despite a high level of analytical specificity (9), the clinical specificity of FA-ME is lower, and further testing for quantitative viral load value may assist in determining how meaningful a positive FA-ME result is and also in monitoring viral load in cases of true infection.”
BackgroundSelf-citationCommunity-acquired bacterial meningitis
Costerus, J. M., Brouwer, M. C., Bijlsma, M. W., & van de Beek, D. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000335 · Cited by 63
Blaschke, A. J., Holmberg, K. M., Daly, J. A., Leber, A. L., Dien Bard, J., Korgenski, E. K., Bourzac, K. M., & Kanack, K. J. (2018) · Journal of clinical microbiology · doi:10.1128/jcm.00277-18 · Cited by 57
“We performed a retrospective evaluation of clinical and outcome data for 145 infants 1 to 60 days old enrolled in the performance evaluation for the FilmArray (BioFire Diagnostics, LLC, Salt Lake City, UT) Meningitis/Encephalitis (ME) panel (12) at three sites.”
BackgroundMethodResultInfluentialSelf-citationBroadhurst, M. J., Dujari, S., Budvytiene, I., Pinsky, B. A., Gold, C. A., & Banaei, N. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00311-20 · Cited by 57
“Although many institutions have already implemented and some studies recommend the clinical adoption of the ME panel for near-patient testing, anticipating that it will improve clinical and antimicrobial stewardship outcomes (3, 6), the overutilization (7) and false-positive results (5) reported in published studies c…”
ResultDumkow, L. E., Worden, L. J., & Rao, S. N. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab245 · Cited by 57
Bacterial meningitis in Africa
Barichello, T., Catalão, C. H. R., Rohlwink, U. K., van der Kuip, M., Zaharie, D., Solomons, R., van Toorn, R., van Furth, A. M., Hasbun, R., Iovino, F., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.822575 · Cited by 76
“monocytogenes with high sensitivity and specificity (215).”
Candel, F. J., Salavert, M., Cantón, R., del Pozo, J. L., Galán‐Sánchez, F., Navarro, D., Rodríguez, A. H., Rodríguez, J. C., Rodríguez-Aguirregabiria, M., Suberviola, B., et al. (2024) · Critical Care · doi:10.1186/s13054-024-05224-3 · Cited by 84
“While both panels detect almost the same pathogens, QIAstat-Dx Meningitis/Encephalitis includes additional pathogens like M. pneumoniae and S. pyogenes but do not include cytomegalovirus [164, 165].”
Comparative genomic, transcriptomic, and proteomic reannotation of human herpesvirus 6
Greninger, A. L., Knudsen, G. M., Roychoudhury, P., Hanson, D. J., Sedlak, R. H., Xie, H. J., Guan, J., Nguyen, T., Peddu, V., Boeckh, M., et al. (2018) · BMC Genomics · doi:10.1186/s12864-018-4604-2 · Cited by 48
“Of note, HHV-6 has recently been included in new, rapid, pointof-care multiplex PCR panels for meningitis/encephalitis and febrile illness [15].”
BackgroundLee, S. H., Chen, S.-Y., Chien, J.-Y., Lee, T.-F., Chen, J.-M., & Hsueh, P.-R. (2019) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2019.04.005 · Cited by 54
Fungal Infections of the Central Nervous System in Children
McCarthy, M. W., Kalasauskas, D., Petraitis, V., Petraitienė, R., & Walsh, T. J. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix059 · Cited by 55
“6 • JPIDS 2017:XX (XX XXXX) • McCarthy et al encephalitis panel, which targets 17 pathogens, including C neoformans/gattii, has been used to diagnose CM in pediatric patients [110].”
Hanson, K. E. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01255-16 · Cited by 52
“support FDA clearance of the ME panel (2).”
BackgroundResultLewinski, M. A., Alby, K., Babady, N. E., Butler‐Wu, S. M., Bard, J. D., Greninger, A. L., Hanson, K. E., Naccache, S. N., Newton, D. W., Temple‐Smolkin, R., et al. (2023) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2023.08.005 · Cited by 61
Self-citationLiu, B., Forman, M., & Valsamakis, A. (2019) · Journal of Virological Methods · doi:10.1016/j.jviromet.2019.113690 · Cited by 52
Herpesvirus-Associated Encephalitis: an Update
Matthews, E., Beckham, J. D., Piquet, A. L., Tyler, K. L., Chauhan, L., & Pastula, D. M. (2022) · Current Tropical Medicine Reports · doi:10.1007/s40475-022-00255-8 · Cited by 60
Van, T. T., Kim, T. H., & Butler-Wu, S. M. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.01.007 · Cited by 49
Boudet, A., Pantel, A., Carles, M.-J., Boclé, H., Charachon, S., Enault, C., Stéphan, R., Cadot, L., Lavigne, J.-P., & Marchandin, H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0223887 · Cited by 49
“5% [9], and in studies re-examining CSF with negative results by other methods showing that 20–23% of patients had a positive FA-M/E assay [14,24].”
BackgroundResultInfluentialAzad, M. A., & Patel, R. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00104-23 · Cited by 62
“The microorganisms included in the BioFire Meningitis/Ence phalitis panel are not well-matched to pathogens associated with neurosurgical IAIs (251, 252).”
BackgroundDittrich, T. D., Marsch, S. C. U., Egli, A., Rüegg, S. J., Marchis, G. M. D., Tschudin‐Sutter, S., & Sutter, R. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-05022-6 · Cited by 45
Assessment of the FilmArray ME Panel in 4199 Consecutively Tested Cerebrospinal Fluid Samples
Lindström, J., Elfving, K., Lindh, M., Westin, J., & Studahl, M. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.05.017 · Cited by 48
Graff, K. E., Dominguez, S. R., & Messacar, K. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab067 · Cited by 50
Treatment of Viral Encephalitis
Aksamit, A. J. (2020) · Neurologic Clinics · doi:10.1016/j.ncl.2020.09.011 · Cited by 44
Posnakoglou, L., Siahanidou, T., Syriopoulou, V., & Michos, A. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03986-6 · Cited by 42
“FA-ME can detect the following pathogens: cytomegalovirus (CMV), enterovirus (EV), herpes simplex viruses (HSV) 1/2, human herpes virus 6 (HHV-6), human parechovirus (HPeV), varicella zoster virus (VZV), Cryptococcus neoformans/gattii, Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meni…”
BackgroundWidyadharma, I. P. E., Sari, N. N. S. P., Pradnyaswari, K. E., Yuwana, K. T., Adikarya, I. P. G. D., Tertia, C., Wijayanti, I. A. S., Indrayani, I. A. S., & Utami, D. K. I. (2020) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-020-00258-0 · Cited by 54
“Studies have conducted that SARS CoV-2 rarely attacks the nervous system through this pathway [40].”
BackgroundAssociation of the filmarray meningitis/encephalitis panel with clinical management
Nabower, A. M., Miller, S., Biewen, B., Lyden, E., Goodrich, N., Miller, A., Gollehon, N., Skar, G., & Snowden, J. (2019) · Hospital Pediatrics · doi:10.1542/hpeds.2019-0064 · Cited by 42
Hagen, A., Eichinger, A., Meyer-Buehn, M., Schober, T., & Huebner, J. (2020) · BMC Pediatrics · doi:10.1186/s12887-020-1944-2 · Cited by 41
Tarai, B., & Das, P. (2019) · Neurological Sciences · doi:10.1007/s10072-018-3584-y · Cited by 41
Precit, M. R., Yee, R., Pandey, U., Fahit, M., Pool, C., Naccache, S. N., & Dien Bard, J. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.01592-19 · Cited by 39
“Nevertheless, our results may not reflect findings in other institutions, as previous studies evaluating the diagnostic performance of FA-M/E have reported incidences of both false-positive and false-negative results (4, 40) compared to goldstandard methods and clinical presentation/diagnosis.”
ResultWagner, K., Springer, B., Pires, V. P., & Keller, P. M. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.01492-17 · Cited by 45
“However, their application as a first-line test in diagnostics remains controversial (38), as highly multiplexed assays have shown high proportions of false-positive results (36).”
O’Halloran, J. A., Franklin, A., Lainhart, W., Burnham, C.-A., Powderly, W., & Dubberke, E. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx242 · Cited by 39
“The clinical assay performance of the FilmArray ME Panel was assessed in a multicenter study that examined 1560 residual CSF samples from patients undergoing lumbar puncture at 11 sites across the United States [6].”
MethodSarma, A., Hanzlik, E., Krishnasarma, R., Pagano, L. M., & Pruthi, S. (2019) · American Journal of Neuroradiology · doi:10.3174/ajnr.a6118 · Cited by 40
“Historically, many cases of neonatal meningoencephalitis have had no specific identifiable cause.(1-10) Human parechovirus”
BackgroundHansen, M. L., & Crum‐Cianflone, N. F. (2019) · Infectious Diseases and Therapy · doi:10.1007/s40121-019-0233-6 · Cited by 43
Ramachandran, P., Wilson, M. R., Catho, G., Rohner, G. B., Schiess, N., Cohrs, R. J., Boutolleau, D., Burrel, S., Yoshikawa, T., Wapniarski, A. E., et al. (2021) · Viruses · doi:10.3390/v13112286 · Cited by 34
“Specificity of mNGS and the Biofire Filmarray Encephalitis Panel In an analysis of specificity of the Biofire meningitis/encephalitis panel by the Biofire Company, they reported 1/7 false-positive results for VZV [33].”
Non-culture based assays for the detection of fungal pathogens
Otašević, S., Momčilović, S., Stojanović, N. M., Skvarč, M., Rajković, K., & Arsić-Arsenijević, V. S. (2018) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2018.03.001 · Cited by 37
Bårnes, G. K., Gudina, E. K., Berhane, M., Abdissa, A., Tesfaw, G., Abebe, G., Feruglio, S. L., Caugant, D. A., & Jørgensen, H. J. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3589-4 · Cited by 37
“Analyses were performed according to the manufacturer’s instructions [18].”
MethodDiagnostic Testing of Neurologic Infections
Ramachandran, P., & Wilson, M. R. (2018) · Neurologic Clinics · doi:10.1016/j.ncl.2018.07.004 · Cited by 40
Eliassen, E., Hemond, C. C., & Santoro, J. D. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.10.004 · Cited by 37
Cost of managing meningitis and encephalitis among infants and children in the United States
Balada-Llasat, J.-M., Rosenthal, N. A., Hasbun, R., Zimmer, L., Bozzette, S. A., Duff, S. B., Chung, J., & Ginocchio, C. C. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.10.012 · Cited by 42
Self-citationPfefferle, S., Christner, M., Aepfelbacher, M., Lütgehetmann, M., & Rohde, H. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4904-4 · Cited by 36
Clinical, laboratory and immune aspects of Zika virus-associated encephalitis in children
Salgado, D. M., Vega, R., Rodríguez, J. A., et al. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.10.030 · Cited by 34
Duff, S., Hasbun, R., Ginocchio, C. C., Balada-Llasat, J.-M., Zimmer, L., & Bozzette, S. A. (2018) · Future Microbiology · doi:10.2217/fmb-2017-0238 · Cited by 31
Self-citationBeganovic, M., McCreary, E. K., Mahoney, M. V. G., Dionne, B., Green, D. A., & Timbrook, T. T. (2019) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2018.026450 · Cited by 38
“Highly contagious CNS pathogens, particularly Neisseria meningitidis, can rapidly lead to shock and multiorgan failure without treatment and pose significant infection control implications that require prompt identification via RDT coupled with recommendations from a multidisciplinary ASP (64).”
BackgroundInfluentialAnand, V., Holmen, J., Neely, M., Pannaraj, P. S., & Dien Bard, J. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01160-16 · Cited by 30
Self-citationLewis, P. O., Lanier, C. G., Patel, P. D., Krolikowski, W. D., & Krolikowski, M. A. (2020) · Medical Mycology · doi:10.1093/mmy/myz064 · Cited by 35
Messacar, K., Palmer, C., Gregoire, L., Elliott, A., Ackley, E., Perraillon, M. C., Tyler, K. L., & Dominguez, S. R. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.02.002 · Cited by 34
O’Brien, M. P., Francis, J. R., Marr, I. M., & Baird, R. W. (2018) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000001936 · Cited by 33
Update and new insights in encephalitis
Mailles, A., Stahl, J. ‐., & Bloch, K. C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.05.002 · Cited by 38
Metadata
- Authors
- Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., Reed, S. L., Chapin, K. C., LeBlanc, L., Johnson, J. K., Soliven, N. L., Carroll, K. C., Miller, J.-A., Dien Bard, J., Mestas, J., Bankowski, M., Enomoto, T., Hemmert, A. C., & Bourzac, K. M.
- Affiliations
- Nationwide Children's Hospital (US)
- The Ohio State University Wexner Medical Center (US)
- Primary Children's Hospital (US)
- Detroit Medical Center (US)
- Loyola University Medical Center (US)
- University of California San Diego (US)
- Rhode Island Hospital (US)
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Hospital (US)
- Children's Hospital Los Angeles, Los Angeles, California, USA
- Children's Hospital Los Angeles (US)
- University of Hawaiʻi at Mānoa (US)
- Diagnostic Laboratory Services (The Queen's Medical Center), Aiea, Hawaii, USA
- BioFire Diagnostics (United States) (US)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-09
- Volume
- 54
- Issue
- 9
- Pages
- 2251-2261
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5005480
- OpenAlex
- W2460625652
- Cited by
- 609
- References
- 54
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 48 · 2023: 61 · 2022: 62 · 2021: 68 · 2020: 92 · 2019: 75 · 2018: 59 · 2017: 31 · 2016: 14
- FWCI
- 58.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- FilmArray Meningitis/Encephalitis panel, infectious meningitis, encephalitis, cerebrospinal fluid, multiplex PCR, pathogen detection, sensitivity and specificity, Neisseria meningitidis, Streptococcus agalactiae, herpes simplex virus, cytomegalovirus, Cryptococcus neoformans, Listeria monocytogenes, Escherichia coli K1, Haemophilus influenzae, varicella-zoster virus, human herpesvirus 6, enterovirus, antimicrobial stewardship
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Bacterial Infections, Cerebrospinal Fluid, Child, Child, Preschool, Encephalitis, Female, Fungi, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Prospective Studies, Sensitivity and Specificity, Time Factors, Virus Diseases, Viruses, Central Nervous System Fungal Infections, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.